Your browser doesn't support javascript.
loading
Comprehensive Comparison Between Adjuvant Targeted Therapy and Chemotherapy for EGFR-Mutant NSCLC Patients: A Cost-Effectiveness Analysis.
Li, Wenqian; Guo, Hanfei; Li, Lingyu; Cui, Jiuwei.
Affiliation
  • Li W; Cancer Center, The First Hospital of Jilin University, Changchun, China.
  • Guo H; Cancer Center, The First Hospital of Jilin University, Changchun, China.
  • Li L; Cancer Center, The First Hospital of Jilin University, Changchun, China.
  • Cui J; Cancer Center, The First Hospital of Jilin University, Changchun, China.
Front Oncol ; 11: 619376, 2021.
Article in En | MEDLINE | ID: mdl-33842322
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Language: En Journal: Front Oncol Year: 2021 Document type: Article Affiliation country: China Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Language: En Journal: Front Oncol Year: 2021 Document type: Article Affiliation country: China Country of publication: Switzerland